Education
About Us
Working with TipRanks
Follow Us
Hydration Pharmaceuticals Co. Ltd. (AU:HPC)
ASX:HPC
RESEARCH TOOLSreports
HPC Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume65.65K
Average Volume (3M)427.63K
Market Cap
AU$5.17M
Enterprise ValueAU$8.25M
Total Cash (Recent Filing)AU$3.22M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-1.44
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding430,800,930
10 Day Avg. Volume255,405
30 Day Avg. Volume427,632
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hydration Pharmaceuticals Co. Ltd. News
HPC FAQ
What was Hydration Pharmaceuticals Co. Ltd.’s price range in the past 12 months?
Hydration Pharmaceuticals Co. Ltd. lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is Hydration Pharmaceuticals Co. Ltd.’s market cap?
Hydration Pharmaceuticals Co. Ltd.’s market cap is AU$5.17M.
When is Hydration Pharmaceuticals Co. Ltd.’s upcoming earnings report date?
Hydration Pharmaceuticals Co. Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 5 days.
How were Hydration Pharmaceuticals Co. Ltd.’s earnings last quarter?
Hydration Pharmaceuticals Co. Ltd. released its earnings results on Feb 28, 2025. The company reported AU$0.014 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.014.
Is Hydration Pharmaceuticals Co. Ltd. overvalued?
According to Wall Street analysts Hydration Pharmaceuticals Co. Ltd.’s price is currently Overvalued.
Does Hydration Pharmaceuticals Co. Ltd. pay dividends?
Hydration Pharmaceuticals Co. Ltd. does not currently pay dividends.
What is Hydration Pharmaceuticals Co. Ltd.’s EPS estimate?
Hydration Pharmaceuticals Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hydration Pharmaceuticals Co. Ltd. have?
Hydration Pharmaceuticals Co. Ltd. has 430,800,930 shares outstanding.
What happened to Hydration Pharmaceuticals Co. Ltd.’s price movement after its last earnings report?
Hydration Pharmaceuticals Co. Ltd. reported an EPS of AU$0.014 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Hydration Pharmaceuticals Co. Ltd.?
Currently, no hedge funds are holding shares in AU:HPC
Hydration Pharmaceuticals Co. Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:HPC Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth AU$6.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
40.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.38%
Trailing 12-Months
Company Description
Hydration Pharmaceuticals Co. Ltd.
Hydration Pharmaceuticals Co. Ltd. (HPC) is a company specializing in the development, manufacturing, and distribution of innovative hydration solutions. Operating within the health and wellness sector, HPC focuses on providing high-quality, scientifically-backed products designed to improve hydration and overall well-being. Their core product offerings include electrolyte-infused beverages, hydration powders, and supplements tailored to meet the needs of diverse consumer groups, including athletes, health enthusiasts, and individuals seeking enhanced hydration solutions.
Technical Analysis
Ownership Overview
31.13% Insiders
―
Mutual Funds
― Other Institutional Investors
68.87% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---